RHINARIS NASAL GEL
RHINARIS NASAL GEL
Approved
DIN Number
02352699
Drug Class
Human
Market Date
Nov 24, 2011
Company
HC
pendopharm division of pharmascience inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02352699
AIG Number0215107001
Classification & Schedule
C
Drug Class
Human
S
Schedule
OTC
A
ATC Code
R01AX10 VARIOUS
Product Specifications
Dosage FormGel
Route of AdministrationNasal
AHFS Classification52:92.00
Health Canada Classification
ACTIVE INGREDIENTS (2)
MACROGOLActive
Strength: 15 %
Monograph: MACROGOL
PROPYLENE GLYCOLActive
Strength: 20 %
Monograph: PROPYLENE GLYCOL